TZ2-GLP
A synthetic dual receptor agonist that targets both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is studied for its role in metabolic regulation, insulin sensitivity, and energy balance.
Research Focus
- Mechanisms of incretin pathway activation and metabolic control.
- Effects on insulin secretion and glucose utilization.
- Appetite regulation and reduction in food intake.
- Decrease in visceral fat mass and enhancement of lipid oxidation.
- Preservation of lean tissue during fat reduction.
Mechanisms Under Study
- Dual activation of GIP and GLP-1 receptors for improved glycemic control.
- Hormonal cross-talk influencing nutrient sensing and energy expenditure.
- Integrated metabolic effects leading to improved body composition.
Product Information
- Supplied as a lyophilized sterile powder.
- Third-party verified for purity, molecular identity, and composition.
- For laboratory research use only, not for human or animal use.
